Scientific degree (chemistry or biology) plus a minimum 10-15 years’ experience in a clinical stage cell therapy, pharmaceutical or biotechnology company….
From Sequoia – 21 Nov 2015 04:06:18 GMT
– View all San Diego jobs
Project Coordinator/Manager – WorldClass Scientific & Technical Information Firm
A worldwide leader in the area of scientific and technical information has an immediate opening for a bright and motivated individual with project management or account […]
Immediate opening for Licensed Clinical Laboratory Technologist
Sabre Sciences, a leader in endocrine research, amino acid balancing and transdermal hormone replacement therapy, has an exciting career opportunity in the research laborato […
As a Clinical Laboratory Scientist you will be at the forefront of development, evaluation and implementation of new technology for clinical and research laboratories. Must have a CLS CA license.
? Molecular t […
Congressman sees first-hand San Diego biotech and medical innovations
SAN DIEGO, Nov. 20, 2015 /PRNewswire/ – Today U.S. Congressional Representative (CA-52) Scott Peters toured Avelas Biosciences, a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment. During the visit, he met with local entrepreneurs from Avelas, Avalon Ventures and COI Pharmaceuticals as well as medical innovators from UCSD.
“It was a privilege to host Representative Peters at Avelas Biosciences today,” said Carmine Stengone, president and CEO of Avelas Biosciences. “We appreciate all the work he has done to support medical innovation and the opportunity to showcase our disruptive technology designed to improve cancer surgery and therapeutic targeting. Avelas is a true San Diego biotech innovation story, with San Diego technology, investors, entrepreneurs and medical innovators.”
Avelas Biosciences was founded by Avalon Ventures on technology from the lab of Nobel laureate Roger Y. Tsien, Ph.D., professor of chemistry, biochemistry and pharmacology at UC San Diego. It is headquartered at COI Pharmaceuticals, Avalon’s Community Of Innovation. Avelas is developing AVB-620, a fluorescent, cancer “illuminator” that is designed to enable surgeons to distinguish tumor tissue from normal during surgery. AVB-620 is in clinical trials for breast cancer under the leadership of Anne Wallace, M.D., director of the Comprehensive Breast Health Center at Moores Cancer Center at UC San Diego Health.
“At UC San Diego, we are committed to translating science discovered in the lab to our cancer patients, to providing access to new and often dramatic technologies through early clinical trials,” said Dr. Wallace. “This partnership between science, clinicians and the community allows us to help bring forward improvements in cancer care for patients here and around the world.”
Representative Peters stated, “Avelas, Avalon and the Community Of Innovation are more examples of San Diego’s leadership in the fields of bioscience and biotechnology. The collaborative approach I saw here today is what sets San Diego apart and why the research performed in San Diego is recognized around the world.”
Earlier this month, Representative Peters was honored by the Healthcare Leadership Council as a “Champion of Healthcare Innovation” in recognition of his support of patient-centered medical progress.
About Avelas Biosciences
Avelas Biosciences is a San Diego-based biotechnology company focused on developing technologies that advance a new standard-of-care for cancer surgery and therapeutic intervention. Lead candidate AVB-620 is in phase 1b trials in up to 39 breast cancer patients, assessing safety, pharmacokinetics and fluorescence properties using tissue image analysis. Avelas was founded by Avalon Ventures on technology from Nobel laureate Roger Y. Tsien, Ph.D. For additional information, please visit www.avelasbio.com.
University of California Disclaimer
The information stated above was prepared by Avelas Biosciences Inc. and reflects solely the opinion of the corporation. Nothing in this statement shall be construed to imply any support or endorsement of Avelas Biosciences, Inc. or any of its products, by The Regents of the University of California, its officers, agents and employees.
SOURCE Avelas Biosciences
VTI strives to maintain and inspire professional excellence by providing Commissioning, Qualification, Automation and Validation Services to the Pharmaceutical,…
From Validation Technologies, Inc. – 20 Nov 2015 18:32:51 GMT
Is a premier pharmaceutical chemistry development and manufacturing organization supporting the pharmaceutical and biotechnology industries….
From Pharmatek – 20 Nov 2015 16:51:54 GMT
– View all San Diego jobs
Prior pharmaceutical and biotechnology recruiting experience. Recruit nationally for major Pharmaceutical, Biotechnology and Clinical Research Organizations…
From Catalyst Five – 20 Nov 2015 16:15:56 GMT
– View all San Diego …
So much for lying low. Investors led by Martin Shkreli have bought a majority of the shares of failed South San Francisco, CA-based KaloBios Pharmaceuticals, which has been in dire straits for some…
[[Click headline to continue reading.]]
6+ years of experience in a QA or related role within a biotechnology or pharmaceutical company. Auditor contributes to the on-going enhancement of Intercept’s…
From Intercept Pharmaceuticals – 20 Nov 2015 08:21:06 GMT
– View all San Diego jobs